Literature DB >> 8997565

Relationship between viral genotype and viral load in patients with chronic hepatitis C.

F García1, C Roldàn, J Hernàndez-Quero, M C Bernal, M A Martínez, M A López, G Piédrola, M C Maroto.   

Abstract

To determine the distribution of hepatitis C virus (HCV) genotypes and to related genotype to viral load, genotyping and quantification of viral RNA were carried out in 35 patients with chronic hepatitis C. Subtype 1a was most prevalent (43%), followed by subtypes 1b (23%) and 3a (14%). Mean viral load (log HCV-RNA copies/ml) for subtypes 1b, 1a and 3a was 7.1 +/- 1, 5.6 +/- 1.1 and 4.1 +/- 2.4, respectively. The presence of immunoglobulin M was related to the duration of hepatitis and genotype 1 to a more severe hepatic injury and higher viral load. Differences observed in viral load for a single HCV subtype justify the need to quantify HCV-RNA prior to establishing antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997565     DOI: 10.1007/bf01691224

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease.

Authors:  G Dusheiko; H Schmilovitz-Weiss; D Brown; F McOmish; P L Yap; S Sherlock; N McIntyre; P Simmonds
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

3.  Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.

Authors:  N Kato; O Yokosuka; K Hosoda; Y Ito; M Ohto; M Omata
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

4.  Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment.

Authors:  Z B Yun; O Reichard; M Chen; J Lundeberg; G Norkrans; A Fryden; A Sönnerborg; O Weiland
Journal:  Scand J Infect Dis       Date:  1994

5.  Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.

Authors:  E Silini; F Bono; A Cividini; A Cerino; S Bruno; S Rossi; G Belloni; B Brugnetti; E Civardi; L Salvaneschi
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

6.  Distribution of viral genotypes in Italy determined by hepatitis C virus typing by DNA immunoassay.

Authors:  A Ravaggi; A Zonaro; M G Marin; M Puoti; A Albertini; E Cariani
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

7.  Clinical characteristics and antibody profiles of chronic hepatitis C patients: relation to hepatitis C virus genotypes.

Authors:  N Yuki; N Hayashi; E Mita; H Hagiwara; M Oshita; K Ohkawa; K Katayama; A Kasahara; H Fusamoto; T Kamada
Journal:  J Med Virol       Date:  1995-02       Impact factor: 2.327

8.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

9.  The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use.

Authors:  S C Gordon; R S Elloway; J C Long; C F Dmuchowski
Journal:  Hepatology       Date:  1993-12       Impact factor: 17.425

Review 10.  Variability of hepatitis C virus.

Authors:  P Simmonds
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

View more
  3 in total

1.  Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation.

Authors:  Ashly E Jordan; David C Perlman; Charles M Cleland; Katarzyna Wyka; Bruce R Schackman; Denis Nash
Journal:  J Clin Virol       Date:  2020-01-27       Impact factor: 3.168

2.  Replicative homeostasis III: implications for antiviral therapy and mechanisms of response and non-response.

Authors:  Richard Sallie
Journal:  Virol J       Date:  2007-03-13       Impact factor: 4.099

3.  Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.

Authors:  Nicola Coppola; Rosa Zampino; Caterina Sagnelli; Giulia Bellini; Aldo Marrone; Maria Stanzione; Nicolina Capoluongo; Adriana Boemio; Carmine Minichini; Luigi Elio Adinolfi; Sabatino Maione; Emanuele Miraglia Del Giudice; Evangelista Sagnelli; Francesca Rossi
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.